The Sildenafil
NotebookYour reading index

A little context.
A clearer question.
A conversation with your clinician.

Method & disclosure ↗
Provider notes

CoreAge Rx 4Play

A sponsored look at the ingredients, preparation language and purchase terms behind the 4Play offer.

The Sildenafil Notebook Editorial Desk
October 6, 2026 · AI-assisted · Not medically reviewed

Preparation
Compounded four-ingredient preparation
Advertised offer
$114 advertised package
To confirm
Five 2 mL bottles; assessment and shipping advertised as included. Confirm prescription and refill choice.

Read the formula before the offer

CoreAge Rx 4Play occupies this publication's sponsored first position. CoreAge describes each 2 mL bottle as containing apomorphine 2 mg, sildenafil 40 mg, tadalafil 4 mg and vardenafil 7.5 mg. That description identifies a compounded multi-ingredient preparation. It should not be read as another brand of an approved sildenafil-only tablet. [Product information]

The product page uses oral-suspension language, while the offer page describes a sublingual solution. Confirm the actual supplied preparation, route and directions with the prescribing clinician and dispensing pharmacist. Do not settle that difference by borrowing instructions from a conventional Viagra label. [Offer page]

Separate the package from the personal instructions

The public offer is $114 for five bottles, totaling 10 mL, marketed as a one-month package. The page says assessment and shipping are included and payment occurs only if treatment is prescribed. It also describes an optional automatic-refill arrangement after the first purchase. These are advertised terms, not a record of a purchase tested by this publication.

A package described as one month does not establish how an individual should use it. Ask for the exact prescription and the next charge before choosing a refill arrangement. Confirm how to contact the clinical team if the supplied label or response raises a question.

Keep the combination's evidence question open

FDA does not approve compounded drugs. Sildenafil's approved uses do not establish 4Play's safety, onset, duration or superiority. The Viagra label does not recommend combinations with other PDE5 inhibitors or ED therapies; ask the clinician to explain the rationale, alternatives and risks of the proposed preparation. [FDA] [Viagra labeling]

We have not assessed patient outcomes or verified the marketing's performance claims. Sponsorship changes placement, not that limitation. Read the ingredient and product guide and bring a complete medicine list to the assessment.

Source notes

Checked October 6, 2026. Provider pages establish advertised terms; medical resources provide general context and do not endorse this publication.

  1. CoreAge Rx: 4Play product informationSponsored provider; advertised formulation
  2. CoreAge Rx: 4Play offer and refill termsSponsored provider; advertised terms
  3. FDA: Compounding questions and answersRegulatory explanation
  4. Pfizer: Viagra prescribing and patient informationManufacturer labeling; accessed October 6, 2026